Suggestions
Holli Fultz
Regional Medical Affairs Director, Global Medical Affairs at Gyroscope Therapeutics
Professional Background
Holli Fultz is a self-motivated and results-oriented professional who brings a wealth of experience and knowledge to the pharmaceutical and biotechnology industries. With an impressive career that spans several years, Holli has honed her skills in various areas such as gene therapy, medical devices, and global strategic publication planning. Her expertise lies in managing relationships with global and national key opinion leaders (KOLs) and executing successful product commercialization strategies. As a Senior Director of Clinical Development at Novartis Gene Therapies, Holli demonstrates her exceptional leadership abilities by leading teams towards achieving clinical and developmental goals.
Her previous roles include significant positions in renowned organizations, such as Senior Director of Global Medical Affairs at Gyroscope Therapeutics and Sr. Medical Science Liaison at Enzyvant. Throughout her career, she has been instrumental in connecting cross-functional teams for strategic planning and establishing collaborations within external business partnerships. With a comprehensive understanding of complex therapeutic areas, Holli is well-versed in navigating scientific communication and problem-solving in high-stakes environments, making her a leading figure in the industry.
Education and Achievements
Holli Fultz's educational background lays a solid foundation for her successful career in the pharmaceutical sector. She pursued a Doctor of Pharmacy degree at the University of Cincinnati, where she cultivated her passion for medicinal science and healthcare. Prior to this, she studied Pre-Pharmacy at the University of Kentucky, solidifying her knowledge base in pharmaceutical sciences.
Holli's career journey traverses several influential roles within prestigious organizations. Before taking on her current position at Novartis Gene Therapies, she served as Senior Director of Global Medical Affairs at Gyroscope Therapeutics, where she supervised medical strategies and enhanced healthcare outreach. Her role as Sr. Medical Science Liaison at Enzyvant positioned her as a key player in bridging medical knowledge with clinical practices.
Further showcasing her talent, Holli was formerly the Director of Medical Affairs Field Operations at Ultragenyx Pharmaceutical Inc., where she was a driving force in enhancing the company's medical operations and ensuring top-tier communication through various channels. Her trajectory at Ultragenyx also featured roles as Associate Director and Senior Medical Science Liaison, wherein she enriched her expertise in field operations within the orphan disease sector.
Moreover, her experience extends to key leadership roles at Horizon Pharma plc, Vidara Therapeutics, and Human Genome Sciences/GlaxoSmithKline, underscoring her extensive background in medical affairs. Each position contributed to her comprehension of the complexities of rare diseases, immunology, hematology/oncology, and more, emphasizing her adaptability and knowledge across diverse therapeutic areas.
Notable Specialties
Holli Fultz's specialties are as diverse as they are impressive. Her specialized knowledge spans critical areas, including Gene Therapy in Ophthalmology, Endocrinology, Rare Diseases, and Immunology. Her breadth of expertise also includes genetics, infectious diseases, and hematology/oncology. Holli is particularly well-regarded for her role in addressing Primary Immunodeficiency Diseases and her knowledge of bone marrow transplants and systemic lupus erythematosus.
In addition to her clinical knowledge, Holli excels in her professional skills, which include leading teams, strategic planning and decision-making, and cross-functional collaboration. These capabilities empower her to drive innovation and execute compelling and effective medical communications strategies, aligning stakeholder engagement with organizational objectives. Furthermore, her proficiency in global publication planning and medical affairs elevates her role as an essential contributor to the science and communication processes in the pharmaceutical industry.
Achievements
Holli Fultz's career is marked by numerous achievements that have made a significant impact within the fields she has been a part of. Her leadership abilities have not only fostered successful team dynamics but have also led to enhanced patient outcomes through her commitment to gene therapies and novel medical solutions. By building strong relationships with key opinion leaders and healthcare professionals, she has successfully influenced medical practice guidelines and contributed to significant advancements in treatment protocols.
With a reputation for excellence and innovation, Holli remains a notable figure in the medical affairs sector, continuously striving to leverage scientific knowledge to improve healthcare delivery. Her expansive experience and dedication to healthcare innovation undoubtedly make her an influential thought leader in the realm of pharmaceuticals and biotechnology.
